抑制巨噬细胞VEGFR1 TK信号可抑制子宫内膜异位症的发生。

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-09-01 DOI:10.21873/invivo.14059
Akiko Furue, Masako Honda, Kyoko Hattori, Erina Sato, Atsushi Yamashita, Mayuko Osada, Kanako Hosono, Mariko Kamata, Yoshiya Ito, Masabumi Shibuya, Kazuyoshi Kato, Hideki Amano
{"title":"抑制巨噬细胞VEGFR1 TK信号可抑制子宫内膜异位症的发生。","authors":"Akiko Furue, Masako Honda, Kyoko Hattori, Erina Sato, Atsushi Yamashita, Mayuko Osada, Kanako Hosono, Mariko Kamata, Yoshiya Ito, Masabumi Shibuya, Kazuyoshi Kato, Hideki Amano","doi":"10.21873/invivo.14059","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial growth factor receptor-1 (VEGFR1) is involved in neovascularization, while peritoneal macrophages (PMs) play a critical role in endometriosis development and establishment. We examined the role of VEGFR1 signaling in PMs during endometriosis development using a murine model of ectopic endometrial transplantation.</p><p><strong>Materials and methods: </strong>Endometrial fragments from female wild-type (WT) or VEGFR1 tyrosine kinase-deficient (TK<sup>-/-</sup>) donor mice were implanted into the peritoneal walls of recipient mice, either in a WT→WT or TK<sup>-/-</sup>→TK<sup>-/-</sup> combination. On day 14 after endometrial transplantation, the implant size, neovascular growth-promoting factors, macrophage accumulation in the implants and peritoneal cavity, and cytokine production were assessed. PMs from WT or TK<sup>-/-</sup> mice were transferred into the peritoneal cavity of WT→WT mice and their effects were assessed.</p><p><strong>Results: </strong>Compared to WT→WT mice, TK<sup>-/-</sup>→TK<sup>-/-</sup> mice exhibited smaller implant sizes and reduced neovascularization, including angiogenesis and lymphangiogenesis. This was correlated with an increase in pro-inflammatory (M1) and a decrease in alternative (M2) large peritoneal macrophages (LPMs) within the peritoneal cavity. Transfer of TK<sup>-/-</sup>-PMs into the peritoneal cavity of WT→WT mice reduced endometriosis development and macrophage accumulation. This led to increased expression of M1 macrophage genes and decreased expression of M2 phenotype genes, compared to WT-PMs transfer. PMs from TK<sup>-/-</sup> mice exhibited increased M1-related and decreased M2-related gene expression.</p><p><strong>Conclusion: </strong>Deletion of VEGFR1 TK signaling in PMs suppressed endometriosis progression and neovascularization by increasing M1 LPMs. Specific inactivation of VEGFR1 TK signaling may represent a potential therapeutic target for the management of endometriosis.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 5","pages":"2584-2598"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396080/pdf/","citationCount":"0","resultStr":"{\"title\":\"Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.\",\"authors\":\"Akiko Furue, Masako Honda, Kyoko Hattori, Erina Sato, Atsushi Yamashita, Mayuko Osada, Kanako Hosono, Mariko Kamata, Yoshiya Ito, Masabumi Shibuya, Kazuyoshi Kato, Hideki Amano\",\"doi\":\"10.21873/invivo.14059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial growth factor receptor-1 (VEGFR1) is involved in neovascularization, while peritoneal macrophages (PMs) play a critical role in endometriosis development and establishment. We examined the role of VEGFR1 signaling in PMs during endometriosis development using a murine model of ectopic endometrial transplantation.</p><p><strong>Materials and methods: </strong>Endometrial fragments from female wild-type (WT) or VEGFR1 tyrosine kinase-deficient (TK<sup>-/-</sup>) donor mice were implanted into the peritoneal walls of recipient mice, either in a WT→WT or TK<sup>-/-</sup>→TK<sup>-/-</sup> combination. On day 14 after endometrial transplantation, the implant size, neovascular growth-promoting factors, macrophage accumulation in the implants and peritoneal cavity, and cytokine production were assessed. PMs from WT or TK<sup>-/-</sup> mice were transferred into the peritoneal cavity of WT→WT mice and their effects were assessed.</p><p><strong>Results: </strong>Compared to WT→WT mice, TK<sup>-/-</sup>→TK<sup>-/-</sup> mice exhibited smaller implant sizes and reduced neovascularization, including angiogenesis and lymphangiogenesis. This was correlated with an increase in pro-inflammatory (M1) and a decrease in alternative (M2) large peritoneal macrophages (LPMs) within the peritoneal cavity. Transfer of TK<sup>-/-</sup>-PMs into the peritoneal cavity of WT→WT mice reduced endometriosis development and macrophage accumulation. This led to increased expression of M1 macrophage genes and decreased expression of M2 phenotype genes, compared to WT-PMs transfer. PMs from TK<sup>-/-</sup> mice exhibited increased M1-related and decreased M2-related gene expression.</p><p><strong>Conclusion: </strong>Deletion of VEGFR1 TK signaling in PMs suppressed endometriosis progression and neovascularization by increasing M1 LPMs. Specific inactivation of VEGFR1 TK signaling may represent a potential therapeutic target for the management of endometriosis.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 5\",\"pages\":\"2584-2598\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396080/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.14059\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:子宫内膜异位症的特点是免疫细胞在子宫内膜病变和腹腔内积聚。巨噬细胞有助于子宫内膜异位症病变的生长和新生血管的形成。血管内皮生长因子受体-1 (VEGFR1)参与新生血管的形成,而腹腔巨噬细胞(PMs)在子宫内膜异位症的发展和建立中起着关键作用。我们通过异位子宫内膜移植小鼠模型研究了VEGFR1信号在子宫内膜异位症发展过程中的作用。材料和方法:将雌性野生型(WT)或VEGFR1酪氨酸激酶缺陷(TK-/-)供体小鼠子宫内膜碎片以WT→WT或TK-/-→TK-/-组合的方式植入受体小鼠腹膜壁。在子宫内膜移植后第14天,评估植入物的大小、新生血管生长促进因子、植入物和腹腔内巨噬细胞的积累以及细胞因子的产生。将WT或TK-/-小鼠的PMs转移到WT→WT小鼠的腹腔内,并评估其作用。结果:与WT→WT小鼠相比,TK-/-→TK-/-小鼠的植入物体积更小,新生血管生成和淋巴管生成减少。这与腹膜腔内促炎细胞(M1)的增加和替代(M2)大腹腔巨噬细胞(lpm)的减少有关。将TK-/- PMs转移到WT→WT小鼠腹腔可减少子宫内膜异位症的发生和巨噬细胞的积累。与wt - pm转移相比,这导致M1巨噬细胞基因的表达增加,M2表型基因的表达减少。TK-/-小鼠pmms中m1相关基因表达增加,m2相关基因表达减少。结论:PMs中VEGFR1 TK信号的缺失通过增加M1 lpm抑制子宫内膜异位症的进展和新生血管的形成。VEGFR1 TK信号的特异性失活可能代表子宫内膜异位症管理的潜在治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.

Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.

Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.

Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.

Background/aim: Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial growth factor receptor-1 (VEGFR1) is involved in neovascularization, while peritoneal macrophages (PMs) play a critical role in endometriosis development and establishment. We examined the role of VEGFR1 signaling in PMs during endometriosis development using a murine model of ectopic endometrial transplantation.

Materials and methods: Endometrial fragments from female wild-type (WT) or VEGFR1 tyrosine kinase-deficient (TK-/-) donor mice were implanted into the peritoneal walls of recipient mice, either in a WT→WT or TK-/-→TK-/- combination. On day 14 after endometrial transplantation, the implant size, neovascular growth-promoting factors, macrophage accumulation in the implants and peritoneal cavity, and cytokine production were assessed. PMs from WT or TK-/- mice were transferred into the peritoneal cavity of WT→WT mice and their effects were assessed.

Results: Compared to WT→WT mice, TK-/-→TK-/- mice exhibited smaller implant sizes and reduced neovascularization, including angiogenesis and lymphangiogenesis. This was correlated with an increase in pro-inflammatory (M1) and a decrease in alternative (M2) large peritoneal macrophages (LPMs) within the peritoneal cavity. Transfer of TK-/--PMs into the peritoneal cavity of WT→WT mice reduced endometriosis development and macrophage accumulation. This led to increased expression of M1 macrophage genes and decreased expression of M2 phenotype genes, compared to WT-PMs transfer. PMs from TK-/- mice exhibited increased M1-related and decreased M2-related gene expression.

Conclusion: Deletion of VEGFR1 TK signaling in PMs suppressed endometriosis progression and neovascularization by increasing M1 LPMs. Specific inactivation of VEGFR1 TK signaling may represent a potential therapeutic target for the management of endometriosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信